Yes, fusion imaging is highly effective in monitoring treatment response. PET/CT or PET/MRI scans can be performed at various stages of treatment to evaluate changes in tumor size and metabolic activity. This helps in:
Early Detection of Recurrence: Identifying residual or recurrent disease at an early stage. Treatment Adjustment: Modifying treatment plans based on the tumor's response, thereby improving outcomes. Prognosis Assessment: Providing insights into the effectiveness of the therapy and the likely prognosis.
